SR
Stanley Riddell is a clinical researcher at the University of Washington Seattle. His research focuses on cellular immunotherapy, including engineering T cells to target cancer and other diseases. He has contributed to the development of CAR T-cell therapies and hematopoietic cell transplantation approaches.
- Field
- Medicine · Oncology
- Clarivate categories
- Clinical Medicine
- Affiliation
- University of Washington Seattle, United States